Early disease detection with MyBreathPrint

The Power of Knowing is as Easy as Breathing!

spacer
Vocxi Health Breath Device Technology

Vocxi Health introduces MyBreathPrint®, the innovative, noninvasive early disease detection system that delivers immediate, accurate results with just one minute of breathing: no needles, no radiation, no waiting.

Inhale Hope…
You can know your health status in a matter of seconds, whether at your doctor’s office or, in the future, from the comfort of your own home.

Exhale Doubt…
Breathe for one minute into the MyBreathPrint® device, and your unique BreathPrint is uploaded to our cloud-based platform and delivered to your doctor for immediate analysis and results.

Breathe. Know. Plan.

Vocxi Health Breath Device Technology
vocxi health k9 companion 2

Science inspired by our k9 companions

line right in

What if you could reduce or alleviate the dread, pain, expense, wait and risk of the diagnostic journey by developing a system that can identify disease in the breath like a dog’s nose can, while also improving outcomes through early detection with regular noninvasive, painless screenings?

This question gave birth to Vocxi Health’s vision: to help save millions of lives, one loved one at a time, through early disease detection. Our patented MyBreathPrint system, which centers on an inventive array of sensors that can detect at the parts per billion level, connects volatile organic compound (VOC) signals to diseases through richly comprehensive electrochemical patterns…just like a dog’s nose can.

spacer

Making Late-stage Lung Cancer a Thing of the Past

line right in

Why MyBreathPrint for Early Detection

Vocxi About Strategic Partners icons light blueArtboard 1

Noninvasive

No needles. No radiation. No discomfort. It takes only one minute of breathing to learn your health status and whether you have cancer or not.

Vocxi About Strategic Partners icons Blue revArtboard 2

Accessible

At your doctor’s office or from home, you and your physician will know your health status in a matter of seconds.

Vocxi About Strategic Partners icons light blueArtboard 3

accurate

Our  technology boasts parts per billion sensitivity to measure the thousands of VOCs in the breath to generate your unique BreathPrint®.

Vocxi About Strategic Partners icons light blueArtboard 4

expertise

Developed by a cross-discipline team of scientific, diagnostic and medical-device experts, MyBreathPrint is covered by more than 30 patents with 30-plus pending.

Vocxi About Strategic Partners icons light blueArtboard 5

Validated

Taking advantage of decades of VOC research and in development for a decade, MyBreathPrint has undergone extensive testing and three human clinical studies.

Vocxi About Strategic Partners icons light blueArtboard 6

Adaptable

With one hardware design, MyBreathPrint is scalable and, through its machine learning platform, customizable to detect multiple diseases, ailments and other health issues.

Saving millions of lives, one loved one at a time, through early disease detection

spacer

Be a Part of the Breath-through

line right in

Get Involved and Help Bring MyBreathPrint to Millions of Patients Worldwide!

Vocxi About Strategic Partners icons light blueArtboard 7

Become a
contributing partner

Explore the broad applications of MyBreathPrint — an early disease detection system as noninvasive as one minute of breathing — will have on patients and healthcare outcomes.

Vocxi About Strategic Partners icons light blueArtboard 8

FOR OUR
CLINICAL PARTNERS

The MyBreathPrint system advances your potential to classify patients quickly throughout their journey. Learn how MyBreathPrint can be your diagnostic co-pilot.
spacer

News & Resources

line right in

Keep Up to Date with Vocxi Health and the Latest Scientific News

Vocxi Health is selected out of 400+ companies to present their poster at the 2024 BLUE KNIGHT™ Symposium. Blue Knight is a joint initiative between Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA).

Vocxi Health

Vocxi won the best pitch in the Healthcare/Tech Track out of dozens of leading global health technology companies at Venture Summit West.
Executives from Twin Cities-based startup Vocxi Health described their device that will detect disease by sensing chemicals in a person's breath — specifically what they exhale. Its initial target market is patients suspected of having lung cancer.